Literature DB >> 29348152

Hearing loss with kanamycin treatment for multidrug-resistant tuberculosis in Bangladesh.

Scott K Heysell1,2, Shahriar Ahmed3,2, Md Toufiq Rahman3, Md Wahiduzzaman Akhanda4, A Tucker Gleason5, Andrew Ebers1, Eric R Houpt1, Sayera Banu6.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29348152      PMCID： PMC6230246          DOI： 10.1183/13993003.01778-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  13 in total

1.  Aminoglycoside-induced hearing loss in HIV-positive and HIV-negative multidrug-resistant tuberculosis patients.

Authors:  Tashneem Harris; Soraya Bardien; H Simon Schaaf; Lucretia Petersen; Greetje De Jong; Johannes J Fagan
Journal:  S Afr Med J       Date:  2012-05-08

2.  Diabetes is Associated with Severe Adverse Events in Multidrug-Resistant Tuberculosis.

Authors:  Marcela Muñoz-Torrico; José Caminero-Luna; Giovanni Battista Migliori; Lia D'Ambrosio; José Luis Carrillo-Alduenda; Héctor Villareal-Velarde; Alfredo Torres-Cruz; Héctor Flores-Vergara; Dina Martínez-Mendoza; Cecilia García-Sancho; Rosella Centis; Miguel Ángel Salazar-Lezama; Rogelio Pérez-Padilla
Journal:  Arch Bronconeumol       Date:  2017-01-11       Impact factor: 4.872

3.  Side effects associated with the treatment of multidrug-resistant tuberculosis.

Authors:  T Törün; G Güngör; I Ozmen; Y Bölükbaşi; E Maden; B Biçakçi; G Ataç; T Sevim; K Tahaoğlu
Journal:  Int J Tuberc Lung Dis       Date:  2005-12       Impact factor: 2.373

Review 4.  Short-course treatment for multidrug-resistant tuberculosis: the STREAM trials.

Authors:  Riya Moodley; Thomas R Godec
Journal:  Eur Respir Rev       Date:  2016-03

5.  Reduced Chance of Hearing Loss Associated with Therapeutic Drug Monitoring of Aminoglycosides in the Treatment of Multidrug-Resistant Tuberculosis.

Authors:  R van Altena; J A Dijkstra; M E van der Meer; J F Borjas Howard; J G W Kosterink; D van Soolingen; T S van der Werf; J W C Alffenaar
Journal:  Antimicrob Agents Chemother       Date:  2017-02-23       Impact factor: 5.191

Review 6.  The effect of diabetes on sensorineural hearing loss.

Authors:  Venkata Kakarlapudi; Robert Sawyer; Hinrich Staecker
Journal:  Otol Neurotol       Date:  2003-05       Impact factor: 2.311

7.  Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up.

Authors:  Prahlad Duggal; Malay Sarkar
Journal:  BMC Ear Nose Throat Disord       Date:  2007-11-12

8.  Successful MDR-TB treatment regimens including amikacin are associated with high rates of hearing loss.

Authors:  Chawangwa Modongo; Rafal S Sobota; Boikobo Kesenogile; Ronald Ncube; Giorgio Sirugo; Scott M Williams; Nicola M Zetola
Journal:  BMC Infect Dis       Date:  2014-10-09       Impact factor: 3.090

9.  Audiological Evaluation of Patients Taking Kanamycin for Multidrug Resistant Tuberculosis.

Authors:  Vishal Sharma; Sanjeev Bhagat; Bhimsain Verma; Ravinder Singh; Surinderpal Singh
Journal:  Iran J Otorhinolaryngol       Date:  2016-05

10.  Artificial Intelligence and Amikacin Exposures Predictive of Outcomes in Multidrug-Resistant Tuberculosis Patients.

Authors:  Chawangwa Modongo; Jotam G Pasipanodya; Beki T Magazi; Shashikant Srivastava; Nicola M Zetola; Scott M Williams; Giorgio Sirugo; Tawanda Gumbo
Journal:  Antimicrob Agents Chemother       Date:  2016-09-23       Impact factor: 5.191
View more
  5 in total

1.  Pharmacokinetics and other risk factors for kanamycin-induced hearing loss in patients with multi-drug resistant tuberculosis.

Authors:  Nazanin Ghafari; Richard Court; Maxwell Tawanda Chirehwa; Lubbe Wiesner; Lucretia Petersen; Gary Maartens; Tawanda Gumbo; Helen McIlleron; Lebogang Ramma
Journal:  Int J Audiol       Date:  2019-11-18       Impact factor: 2.117

2.  Predictive model of unfavorable outcomes for multidrug-resistant tuberculosis.

Authors:  Luiz Henrique Arroyo; Antônio Carlos Vieira Ramos; Mellina Yamamura; Thais Zamboni Berra; Luana Seles Alves; Aylana de Souza Belchior; Danielle Talita Santos; Josilene Dália Alves; Laura Terenciani Campoy; Marcos Augusto Moraes Arcoverde; Valdes Roberto Bollela; Sidney Bombarda; Carla Nunes; Ricardo Alexandre Arcêncio
Journal:  Rev Saude Publica       Date:  2019-09-23       Impact factor: 2.106

3.  Case Report: Kanamycin Ototoxicity and MDR-TB Treatment Regimen.

Authors:  Bahru Mantefardo; Gizaw Sisay
Journal:  Int Med Case Rep J       Date:  2021-11-26

4.  A data compendium associating the genomes of 12,289 Mycobacterium tuberculosis isolates with quantitative resistance phenotypes to 13 antibiotics.

Authors: 
Journal:  PLoS Biol       Date:  2022-08-09       Impact factor: 9.593

5.  Validity of automated audiometry for hearing examination in patients with multidrug-resistant tuberculosis.

Authors:  Nyilo Purnami; Rian W Palandeng; Soedarsono -; Dhany Arifianto; In Seok Moon
Journal:  F1000Res       Date:  2021-12-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.